Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO)

(2011) Nicolino Ruperto et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Attainment of Inactive Disease Status Following Initiation of TNF-α Inhibitor Therapy for Juvenile Idiopathic Arthritis: Enthesitis-related Arthritis Predicts Persistent Active Disease

(2011) KATHERINE J. DONNITHORNE et al.   JOURNAL OF RHEUMATOLOGY

Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010

(2011) MARIEKE H. OTTEN et al.   JOURNAL OF RHEUMATOLOGY

Juvenile idiopathic arthritis

(2011) Berent Prakken et al.   LANCET

American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis

(2011) Carol A. Wallace et al.   ARTHRITIS CARE & RESEARCH

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?

(2010) M. H. Otten et al.   ANNALS OF THE RHEUMATIC DISEASES

Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs

(2010) Nicolino Ruperto et al.   ARTHRITIS AND RHEUMATISM

Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis

(2010) V. Papsdorf et al.   RHEUMATOLOGY

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

(2009) J Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

(2008) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of TNFα antagonist therapy in patients with juvenile spondyloarthropathies

(2008) Moana Sulpice et al.   JOINT BONE SPINE

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

(2008) Nicolino Ruperto et al.   LANCET

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group

(2008) J. Thornton et al.   RHEUMATOLOGY